Killing HER2 Softly with Drugs: Novel Therapies for Advanced HER2-Positive Breast Cancer with Brain Metastases – Pharmacy Resident Seminar November 10, 2020
November 10, 2020
12:30 PM - 1:20 PM
Please join us for our next Pharmacy Resident Seminar Presentation on Tuesday, November 10, 2020, via Live Webinar, presented by UIC College of Pharmacy PGY-1 Pharmacy Practice Resident, Sarvnaz Sadrameli, PharmD.
Type of Activity: Knowledge Target Audience: Pharmacists
Time: Tuesday, November 10, 2020, 12:30 pm - 1:20 pm
Fees: There is no charge for attending this activity
Location: Live Webinar
Webex Meeting Information:
Meeting link: https://uichicago.webex.com/uichicago/onstage/g.php?MTID=e40eef610a496b4f2ca35395bc3ec9167
Meeting number: 120 371 9859
Password: 4U7pCXDJMp5
Or
Join by phone: +1-415-655-0001 United States Toll (Chicago)
Learning Objectives :
At the completion of this activity, the participant will be able to:
- Review the prevalence, prognostic factors, and intrinsic subtypes of breast cancer based on their gene expression
- Outline the treatment approach and clinical considerations for HER2-positive metastatic breast cancer
- Explain the pharmacological properties of the novel agents for the treatment of HER2-positive advanced breast cancer with brain metastases
- Discuss place in therapy of the novel agents for the treatment of HER2-positive advanced breast cancer with brain metastases
Disclosure: The speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial conflicts of interest to disclose.
Date posted
Oct 27, 2020
Date updated
Nov 6, 2020
Speakers
